Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Adding TPGS to minoxidil solutions can improve skin penetration and retention, especially in water and PEG 400-based solutions.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

More oxygen isn't always better and can sometimes be worse.

Botulinum toxin may help treat hair loss but needs more research for effectiveness and cost concerns.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Feminizing hormone therapy increases kidney filtration rate.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

Transglutaminases work through a ping-pong mechanism, and human plasma and platelet transglutaminases have similar catalytic subunits.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Ovarian hyperthecosis can cause polycythemia, and surgery can normalize symptoms.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Experts agree on guidelines to treat common hair loss effectively.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.